Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28625707 | 1.00 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL2986700 | 0.98 | GPR84 (0.56) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL28335027 | 0.96 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL11014334 | 0.96 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL10615937 | 0.96 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL28094928 | 0.96 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL14714458 | 0.96 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL27776825 | 0.96 | GPR84 (0.59) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL15234477 | 0.95 | GPR84 (0.56) | GPR84NAAAFFAR1FFAR4DGKA | |
| SCHEMBL19837599 | 0.93 | GPR84 (0.48) | GPR84NAAADGKARAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-08-12 | — | — | US | disclosed |
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | Technische Universität München (DE) | 2021-08-12 | — | — | US | disclosed |
| US-7786355-B2 | Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways | METABOLIX, INC. (US) | 2010-08-31 | — | — | US | disclosed |
| EP-1334181-B1 | PRODUCTION OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES FROM FATTY ACID BIOSYNTHETIC PATHWAYS | METABOLIX INC (US) | 2010-03-17 | — | — | EP | disclosed |
| WO-2002040690-A9 | PRODUCTION OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES FROM FATTY ACID BIOSYNTHETIC PATHWAYS | METABOLIX INC (US) | 2003-11-20 | — | — | WO | disclosed |
| EP-1334181-A2 | PRODUCTION OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES FROM FATTY ACID BIOSYNTHETIC PATHWAYS | METABOLIX, INC. (US) | 2003-08-13 | — | — | EP | disclosed |
| US-20030017576-A1 | Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways | METABOLIX, INC. | 2003-01-23 | — | — | US | disclosed |
| WO-2002040690-A2 | PRODUCTION OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES FROM FATTY ACID BIOSYNTHETIC PATHWAYS | METABOLIX, INC. (US) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210247400-A1 | ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF | PGLS, LIPE, LYPLA2 | GPR84 2281/4885NAAA 181/4885FFAR1 1534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.